The instrument, endowed with €20 millions, aims to invest in companies in the very early stages of development
Caixa Capital Risc led the investment alongside Ysios Capital and the Fundació Vila Casas
The program allows companies to attract talent, collaborate with research centers and obtain financial aid
Capital Cell, which allows anyone to fund projects in biotechnology or life sciences, has closed a round for €125,000
They’ve been granted €50,000 to invest in their innovative projects
Barcelona-based Psious uses 3D simulations to treat phobias and anxiety in psychology and oncology patients
The Girona-based biotechnology firm hopes to develop a more effective preventative system than the fecal occult blood test
The positive results of phase II clinical trials on a drug to treat amyloidosis have led the company to launch this round of funding
The projects are studying spinal muscular atrophy, sudden-death syndrome and Kawasaki disease
Founder and CEO Ignasi Belda says the company is growing much faster than expected
